HOTH THERAPEUTICS INC (HOTH)

US44148G2049 - Common Stock

1.12  -0.05 (-4.27%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HOTH. HOTH was compared to 198 industry peers in the Pharmaceuticals industry. While HOTH has a great health rating, there are worries on its profitability. HOTH is valued expensive and it does not seem to be growing.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HOTH has reported negative net income.
In the past year HOTH has reported a negative cash flow from operations.
In the past 5 years HOTH always reported negative net income.
HOTH had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

HOTH's Return On Assets of -82.37% is on the low side compared to the rest of the industry. HOTH is outperformed by 74.87% of its industry peers.
HOTH's Return On Equity of -88.96% is in line compared to the rest of the industry. HOTH outperforms 41.03% of its industry peers.
Industry RankSector Rank
ROA -82.37%
ROE -88.96%
ROIC N/A
ROA(3y)-126.94%
ROA(5y)-157.87%
ROE(3y)-151.97%
ROE(5y)-186.32%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HOTH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

7

2. Health

2.1 Basic Checks

HOTH has more shares outstanding than it did 1 year ago.
HOTH has more shares outstanding than it did 5 years ago.
There is no outstanding debt for HOTH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -4.97, we must say that HOTH is in the distress zone and has some risk of bankruptcy.
HOTH's Altman-Z score of -4.97 is on the low side compared to the rest of the industry. HOTH is outperformed by 61.54% of its industry peers.
There is no outstanding debt for HOTH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.97
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 13.89 indicates that HOTH has no problem at all paying its short term obligations.
HOTH's Current ratio of 13.89 is amongst the best of the industry. HOTH outperforms 90.26% of its industry peers.
A Quick Ratio of 13.89 indicates that HOTH has no problem at all paying its short term obligations.
HOTH's Quick ratio of 13.89 is amongst the best of the industry. HOTH outperforms 90.77% of its industry peers.
Industry RankSector Rank
Current Ratio 13.89
Quick Ratio 13.89

More info and screens

1

3. Growth

3.1 Past

HOTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.08%, which is quite impressive.
EPS 1Y (TTM)76.08%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q88.81%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

HOTH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.86% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y21.89%
EPS Next 2Y22.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

HOTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HOTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

HOTH's earnings are expected to grow with 22.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.86%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HOTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HOTH THERAPEUTICS INC

NASDAQ:HOTH (4/26/2024, 10:22:36 AM)

1.12

-0.05 (-4.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.93M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -82.37%
ROE -88.96%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 13.89
Quick Ratio 13.89
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)76.08%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y21.89%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y